You are here

Article info

Article menu
Download PDFPDF
EULAR 2014: Scientific Abstracts
Poster Presentations. Scleroderma, myositis and related syndromes - etiology, pathogenesis and animal models
FRI0516 Paquinimod (ABR-215757), an Immunomodulatory Compound, Reduces Fibrosis in the Tight Skin-1 (TSK-1) Model for Systemic Sclerosis

Authors

Citation

Stenström M, Carlsson Nyhlén H, Nilsson M, et al
FRI0516 Paquinimod (ABR-215757), an Immunomodulatory Compound, Reduces Fibrosis in the Tight Skin-1 (TSK-1) Model for Systemic Sclerosis
Annals of the Rheumatic Diseases 2014;73:574.

Publication history

  • First published June 10, 2014.
Online issue publication 
February 22, 2018

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

© 2014, Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions